The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor-Reference-Cited by-同舟云学术

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

Published:2008 Issue:4 Volume:112 Page:800-805
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Dash Atreya,Carver Brett S.,Stasi Jason,Bajorin Dean F.,Motzer Robert J.,Bosl George J.,Sheinfeld Joel

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. The Management of Patients with Nonseminomatous Germ Cell Tumors of the Testis with Serologic Disease Only After Orchiectomy

2. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma

3. The Management of Patients with Clinical Stage I Nonseminomatous Testicular Tumors and Persistently Elevated Serologic Markers

4. National Comprehensive Cancer Network. Testicular Cancer. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, version 1, 2007. Available at URL: http://www.nccn.org/professionals/physician_gls/PDF/testicular.pdf Accessed May 28, 2007.

5. Late relapse of testicular germ cell tumors

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term retroperitoneal lymph node dissection outcomes for nonseminomatous germ cell tumors with postchemotherapy retroperitoneal residual tumors, in a specialized hospital of Saudi Arabia;Urology Annals;2023

2. Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer;World Journal of Urology;2021-12-02

3. Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors;Translational Andrology and Urology;2020-01

4. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group;Journal of Urology;2019-10

5. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer;Urologic Oncology: Seminars and Original Investigations;2019-03